Travelers Cos. Adjusts Valuation Grade Amid Strong Financial Performance Indicators
The Travelers Cos., Inc. has recently adjusted its valuation grade to fair. Key financial metrics include a P/E ratio of 49, a price-to-book value of 7.46, and a high enterprise value to EBITDA ratio of 301.26. The company reported strong operating cash flow and a low debt-equity ratio.
The Travelers Cos., Inc., a prominent player in the insurance industry, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the company's valuation grade, now categorized as fair, compared to its previous classification. Key financial metrics provide insight into the company's current standing. The price-to-earnings (P/E) ratio stands at 49, indicating a premium valuation relative to earnings. Additionally, the price-to-book value is recorded at 7.46, while the enterprise value to EBITDA ratio is notably high at 301.26. The enterprise value to capital employed ratio is 6.88, and the enterprise value to sales ratio is 4.53. The company's PEG ratio is 1.31, suggesting a balanced growth perspective.
Despite the adjustment in evaluation, Travelers has demonstrated positive financial performance in the recent quarter ending June 2025, with operating cash flow reaching USD 9,633 million and a return on equity (ROE) of 15.15%. The company also boasts a low debt-equity ratio of 24.98%, alongside a robust institutional holding of 86.52%, reflecting strong confidence from larger investors.
For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
